Dextran's antithrombotic properties in small arteries are not altered by low‐molecular‐weight heparin or the fibrinolytic inhibitor tranexamic acid: An experimental study
- 1 January 1993
- journal article
- research article
- Published by Wiley in Microsurgery
- Vol. 14 (4) , 289-295
- https://doi.org/10.1002/micr.1920140415
Abstract
In two separate blind, randomized studies, 48 rabbits were divided into five groups. Three treated groups received dextran 70 (0.51 g/kg) as a single injection, dextran 70 combined with low molecular-weight heparin (LMWH) (560 IU/kg as anti-FXa and 140 IU/kg as APTT in 3 hr), and dextran 70 plus tranexamic acid (14 mg/kg) following severe arterial trauma (arteriotomylintimectomy). Two control groups received the same amount of saline. The bleeding times from the arteriotomy were recorded, and patency rates and the weight of thrombotic materials were registered 2 hr after reperfusion of the trauma region. The bleeding times in three treated groups, all including dextran, were significantly prolonged compared to the control groups (P < 0.05 or 0.01). The patency rates of treated groups, which were 100% (1 8/18 vessels patent) in the dextran-treated group, 90% (18/20 vessels patent) in the dextran + LMWH group and 95% 19/20 vessels patent) in dextran + tranexamic acid group, were significantly higher than those of their control groups (55-67% patent vessels) (p < 0.05 or 0.01). The mean weights of thrombotic materials were significantly reduced in the treated groups compared to the corresponding control groups (p < 0.01). In conclusion, dextran 70 in an ordinary dose exerted such a profound antithrombotic effect (100% patency) in small traumatized arteries that the addiiion of a high dose of LMWH could not further improve patency rates or decrease thrombotic materials but did not prolong vessel bleeding times compared to the single dextran treatment. The addition to dextran 70 treatment of a clinical dose of the antifibrinolytic agent tranexamic acid did not disturb the good antithrombotic effect, suggesting that fibrinolysis enhancement is a less important characteristic of the dextran antithrombotic effect in small traumatized arteries. © 1993 Wiley-Liss Inc.Keywords
This publication has 12 references indexed in Scilit:
- Low-molecular-weight heparin exerts an early antithrombotic effect in small arteries and veins following severe traumaMicrosurgery, 1992
- Studies of the antithrombotic effects of dextran 40 following microarterial traumaBritish Journal of Plastic Surgery, 1991
- Selective heparinization of venous anastomosis in latissimus dorsi free flaps to cover lower‐extremity soft‐tissue defectsMicrosurgery, 1991
- Prevention of Venous Thromboembolism in General Surgical PatientsAnnals of Surgery, 1988
- Clinical Use of Low Molecular Weight Heparins and HeparinoidsSeminars in Thrombosis and Hemostasis, 1988
- Early Microsurgical Reconstruction of Complex Trauma of the ExtremitiesPlastic and Reconstructive Surgery, 1986
- Effect of dextran 70 and saline on thrombus formation following arteriotomy and intimectomy in small arteriesMicrosurgery, 1986
- On the interaction between dextran and the primary fibrinolysis inhibitor α2-antiplasminThrombosis Research, 1980
- Effect of dextran on fibrinolysis inhibition activity in serumThrombosis Research, 1978
- The Effect of Dextran on the Lysability of Ex Vivo ThrombiAnnals of Surgery, 1975